Johnson & Johnson ( JNJ ) will begin trading ex-dividend on August 22, 2014. A cash dividend payment of $0.7 per share is scheduled to be paid on September 09, 2014. Shareholders who purchased JNJ stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 6.06% increase over the same period a year ago. At the current stock price of $103.21, the dividend yield is 2.71%.
The previous trading day's last sale of JNJ was $103.21, representing a -3.31% decrease from the 52 week high of $106.74 and a 20.71% increase over the 52 week low of $85.50.
JNJ is a part of the Health Care sector, which includes companies such as Novartis AG ( NVS ) and Pfizer, Inc. ( PFE ). JNJ's current earnings per share, an indicator of a company's profitability, is $5.42. Zacks Investment Research reports JNJ's forecasted earnings growth in 2014 as 7.2%, compared to an industry average of .5%.
Interested in gaining exposure to JNJ through an Exchange Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- Select Sector SPDR Fund - Health Care ( XLV )
- iShares Dow Jones U.S. Health Care Index Fund ( IYH )
- Merrill Lynch Pharmaceutical HOLDRS ( PPH )
- Vanguard Health Care ETF ( VHT )
- iShares U.S. Pharmaceutical ETF ( IHE ).
The top-performing ETF of this group is VHT with an increase of 9.33% over the last 100 days. XLV has the highest percent weighting of JNJ at 12.77%.